Agopton 30 mg, magensaftresistente Hartkapseln

7680519690140 CH-51969 Magensaftresistente Hartkapseln

Associated product:

AGOPTON caps 30 mg 14 pce
Agopton 30 mg, magensaftresistente Hartkapseln
Agopton 30 mg, magensaftresistente Hartkapseln
Agopton 30 mg, magensaftresistente Hartkapseln
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Kapsel(n)
Galenic form
Magensaftresistente Hartkapseln
Galenic group
Gastrointenstinales Therapiesystem

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/05/2025
Patient information leaflet
Français
15/05/2025
Patient information leaflet
Italien
15/05/2025
Summary of Product Characteristics
Allemand
15/05/2025
Summary of Product Characteristics
Français
15/05/2025
Summary of Product Characteristics
Italien
15/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 26.75
Specialties list
Yes
Generic
No
SL addition date: 15/03/1994

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
51969
Drug name
Agopton, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
A02BC03
Authorization status
Z
Dispensing category
B
First authorization
18/06/1993
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
peptisches Ulcus, gastroösophageale Refluxkrankheit

Package details

Description (FR)
AGOPTON caps 30 mg 14 pce
Description (DE)
AGOPTON Kaps 30 mg 14 Stk
Market launch
18/06/1993
Narcotic (BTM)
No

Available generics (10)

Lansoprazol-Mepha, Kapseln
GTIN: 7680573230016
CHF 36.35
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230030
CHF 46.35
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230245
CHF 14.80
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230269
CHF 26.60
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230283
CHF 35.05
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230306
CHF 49.75
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230054
CHF 46.45
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230320
CHF 26.00
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230344
CHF 33.20
View
Lansoprazol-Mepha, Kapseln
GTIN: 7680573230368
CHF 44.55
View

Other package sizes (10)

AGOPTON caps 30 mg 28 pce
28 KAP
GTIN: 7680519690225
View
AGOPTON caps 30 mg 56 pce
56 KAP
GTIN: 7680519690300
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
AGOPTON caps 15 mg 14 pce
14 KAP
GTIN: 7680519690492
View
AGOPTON caps 15 mg 28 pce
28 KAP
GTIN: 7680519690577
View
AGOPTON caps 15 mg 56 pce
56 KAP
GTIN: 7680519690652
View
AGOPTON caps 15 mg 112 pce
112 KAP
GTIN: 7680519690737
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1